Kangho Suh wrote an excellent article on the use of instrumental variables in healthcare. I agree this technique strengthens causal inference for analyses of observational data. This is even more important when a randomized controlled trial is not feasible or ethical.
SaveSave
Pulled from the Infectious Economics archives, these articles provide recommendations for the design and development of robust mathematical models of COVID-19 epidemiology and economics to reduce uncertainty in decision-making and inform evidence-based public policy. Associations are easy; valid causal inference is hard If we want to be honest in evaluating the winners and losers in…
Want to join our book club? We’re reading the new Causal Inference Book by Miguel Hernan and James Robins. The book is forthcoming publication by Chapman & Hall/CRC and it is available for FREE right now to download from Harvard. Every few weeks my colleagues and I meet up to discuss a few chapters. We…
COVID-19 disparities persist in our most vulnerable communities, including low-income families and racial and ethnic minorities, partly because of the financial necessity to continue working, as well as the lack of employment opportunities that enable their residents to work remotely. They are more likely to be essential workers, and that increases their exposure to the…
Incredible new research from Harvard and Kaiser contributed two substantial leaps forward this summer: first in the useful application of machine learning predictions using electronic health records and second in the accurate targeting of people who can benefit the most from HIV pre-exposure prophylaxis. This paper in Lancet HIV by Marcus and colleagues is so good…
Will HIV vaccines compete with existing HIV prevention strategies? Who is doing COVID vaccine cost-effectiveness analysis? Fred Hutch Science Spotlight translated the math in our peer-reviewed paper published in the Journal of the International AIDS Society to explain the economic tradeoffs of delivering an HIV vaccine in Seattle in the future. Our prior review of…
The best health and economic policies for safe, successful, live theater in 2021-2023 will be dynamic – adapting protocols quickly to new scientific evidence, flexing capacity limits according to vaccination and testing. On Thursday April 1, 2021, the COVID Theatre Think Tank hosted a national town hall for the theatre industry to address the current…